Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

53 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
HA-1-targeted T cell receptor (TCR) T cell therapy for recurrent leukemia after hematopoietic stem cell transplantation.
Krakow EF, Brault M, Summers C, Cunningham TM, Biernacki MA, Black RG, Woodward KB, Vartanian N, Kanaan SB, Yeh AC, Dossa RG, Bar M, Cassaday RD, Dahlberg A, Till BG, Denker AE, Yeung CCS, Gooley TA, Maloney DG, Riddell SR, Greenberg PD, Chapuis AG, Newell EW, Furlan SN, Bleakley M. Krakow EF, et al. Among authors: bleakley m. Blood. 2024 Apr 29:blood.2024024105. doi: 10.1182/blood.2024024105. Online ahead of print. Blood. 2024. PMID: 38683966
Alternative immune effector cells picking up speed.
Weber E, Bleakley M, Cronk JC, Shah NN, Perna F. Weber E, et al. Among authors: bleakley m. Mol Ther. 2024 Mar 6;32(3):563-564. doi: 10.1016/j.ymthe.2024.01.030. Epub 2024 Feb 9. Mol Ther. 2024. PMID: 38340733 No abstract available.
CD19 occupancy may drive CARs further.
Hirayama AV, Bleakley M. Hirayama AV, et al. Among authors: bleakley m. Blood. 2024 Jan 18;143(3):190-192. doi: 10.1182/blood.2023022783. Blood. 2024. PMID: 38236611 No abstract available.
Discovery of U2AF1 neoantigens in myeloid neoplasms.
Biernacki MA, Lok J, Black RG, Foster KA, Cummings C, Woodward KB, Monahan T, Oehler VG, Stirewalt DL, Wu D, Rongvaux A, Deeg HJ, Bleakley M. Biernacki MA, et al. Among authors: bleakley m. J Immunother Cancer. 2023 Dec 12;11(12):e007490. doi: 10.1136/jitc-2023-007490. J Immunother Cancer. 2023. PMID: 38164756 Free PMC article.
MDM2 inhibition augments GVL effect.
Bleakley M, Biernacki M. Bleakley M, et al. Blood. 2022 Sep 8;140(10):1064-1065. doi: 10.1182/blood.2022017724. Blood. 2022. PMID: 36074535 Free article. No abstract available.
Hematopoietic Cell Transplantation in the Treatment of Pediatric Acute Myelogenous Leukemia and Myelodysplastic Syndromes: Guidelines from the American Society of Transplantation and Cellular Therapy.
Tarlock K, Sulis ML, Chewning JH, Pollard JA, Cooper T, Gamis A, Shenoy S, Kutny M, Horan J, Meshinchi S, Boelens JJ, Bleakley M, Carpenter PA, Kolb EA. Tarlock K, et al. Among authors: bleakley m. Transplant Cell Ther. 2022 Sep;28(9):530-545. doi: 10.1016/j.jtct.2022.06.005. Epub 2022 Jun 16. Transplant Cell Ther. 2022. PMID: 35717004 Free article. Review.
Utility of the Treatment-Related Mortality (TRM) score to predict outcomes of adults with acute myeloid leukemia undergoing allogeneic hematopoietic cell transplantation.
Zarling LC, Othus M, Sandmaier BM, Milano F, Schoch G, Davis C, Bleakley M, Deeg HJ, Appelbaum FR, Storb R, Walter RB. Zarling LC, et al. Among authors: bleakley m. Leukemia. 2022 Jun;36(6):1563-1574. doi: 10.1038/s41375-022-01574-5. Epub 2022 Apr 19. Leukemia. 2022. PMID: 35440690 Free PMC article.
Targeting an alternate Wilms' tumor antigen 1 peptide bypasses immunoproteasome dependency.
Lahman MC, Schmitt TM, Paulson KG, Vigneron N, Buenrostro D, Wagener FD, Voillet V, Martin L, Gottardo R, Bielas J, McElrath JM, Stirewalt DL, Pogosova-Agadjanyan EL, Yeung CC, Pierce RH, Egan DN, Bar M, Hendrie PC, Kinsella S, Vakil A, Butler J, Chaffee M, Linton J, McAfee MS, Hunter DS, Bleakley M, Rongvaux A, Van den Eynde BJ, Chapuis AG, Greenberg PD. Lahman MC, et al. Among authors: bleakley m. Sci Transl Med. 2022 Feb 9;14(631):eabg8070. doi: 10.1126/scitranslmed.abg8070. Epub 2022 Feb 9. Sci Transl Med. 2022. PMID: 35138909 Free PMC article.
Naive T-Cell Depletion to Prevent Chronic Graft-Versus-Host Disease.
Bleakley M, Sehgal A, Seropian S, Biernacki MA, Krakow EF, Dahlberg A, Persinger H, Hilzinger B, Martin PJ, Carpenter PA, Flowers ME, Voutsinas J, Gooley TA, Loeb K, Wood BL, Heimfeld S, Riddell SR, Shlomchik WD. Bleakley M, et al. J Clin Oncol. 2022 Apr 10;40(11):1174-1185. doi: 10.1200/JCO.21.01755. Epub 2022 Jan 10. J Clin Oncol. 2022. PMID: 35007144 Free PMC article. Clinical Trial.
53 results